Schizophrenia News and Research

Latest Schizophrenia News and Research

In vivo imaging of α-synuclein aggregates in the brains of living patients with multiple system atrophy

α-synuclein is a neuronal protein involved in functions like vesicle trafficking and neurotransmitter release. It is typically found in abundance in a healthy brain.

30 Aug 2022

Study reveals clues what makes the human brain distinct from others

What makes the human brain distinct from that of all other animals -; including even our closest primate relatives? In an analysis of cell types in the prefrontal cortex of four primate species, Yale researchers identified species-specific -; particularly human-specific -; features, they report Aug. 25 in the journal Science.

26 Aug 2022

From book stacks to psychosis and food stamps, librarians confront a new workplace

For nearly two decades, Lisa Dunseth loved her job at San Francisco's main public library, particularly her final seven years in the rare books department.

23 Aug 2022

New study advances the understanding of genetic basis of autism

A new study of genes underlying neurodevelopmental differences has uncovered more than 70 that are very strongly associated with autism and more than 250 with strong links to the condition.

18 Aug 2022

UNC scientists map the surface of young brain's cortex with unprecedented resolution

Scientists at the UNC School of Medicine have mapped the surface of the cortex of the young human brain with unprecedented resolution, revealing the development of key functional regions from two months before birth to two years after.

18 Aug 2022

The QCOVID4 algorithm developed using data from the Omicron wave identifies those at highest risk of severe COVID-19 outcomes

A recent article illustrated the derivation and validation of the QCOVID4 risk determination algorithm for predicting COVID-19 hospitalization and death risk in England.

18 Aug 2022

Metabolic Mind Award Program recognizes champions in the emerging field of metabolic psychiatry

The Baszucki Brain Research Fund and the Milken Institute's Center for Strategic Philanthropy today announced the launch of the Metabolic Mind Award Program, recognizing champions working at the intersection of metabolism and mental health in the emerging field of metabolic psychiatry. This year's award focus will be on Ketogenic Metabolic Therapy for mental health.

18 Aug 2022

Scientists unravel the development of main immune cell population residing in the brain

New research published today by the University of Southampton shows new insight in how our brain develops, that can pave the way for treating neurological disorders.

16 Aug 2022

Researchers develop a long-acting injectable formulation of the anti-TB drug rifabutin

In 2020, more than 1.5 million people around the world died of tuberculosis, marking the first time in more than a decade that annual TB deaths had increased and demonstrating the global need for better access to treatments.

8 Aug 2022

When mental illness leads to dropped charges, patients often go without stabilizing care

For seven years, Timothy Jay Fowler rotated between jail, forced psychiatric hospitalization, and freedom.

4 Aug 2022

BBRF hosts a free webinar on manipulating memories to help treat brain illness

The Brain & Behavior Research Foundation is hosting a free webinar, "Manipulating Memories to Help Treat Brain Illness" on Tuesday, August 9, 2022, at 2:00 pm EDT.

3 Aug 2022

Neurons show rhythmic activity at different frequencies in the desynchronized state

In the 17th century, the Dutch scientist Christiaan Huygens hanged two of his recently invented pendulum clocks on a wooden beam and observed that as time passed, the clocks aligned their beats.

2 Aug 2022

Study identifies pivotal role of FIBCD1 gene in neurodevelopmental disorders

A multidisciplinary study led by Vanja Nagy (LBI-RUD/CeMM/Medical University of Vienna) and Josef Penninger (UBC/IMBA) characterized a novel gene, known as FIBCD1, to be likely causative of a new and rare neurodevelopmental disorder.

2 Aug 2022

Researchers characterize a novel gene likely to cause neurological disorders in humans

A multidisciplinary study led by Vanja Nagy (LBI-RUD/CeMM/MedUni Vienna) and Josef Penninger (UBC/IMBA) characterized a novel gene, known as FIBCD1, to be likely causative of a new and rare neurodevelopmental disorder. Using data from two young patients with neurological symptoms, the researchers from both groups found evidence of a novel function for the FIBCD1 gene in the brain, and a potentially pivotal role in diseases such as autism, ADHD, schizophrenia, and neurodegenerative disorders including Alzheimer's. The study makes an important contribution to the understanding of the extracellular matrix in the brain and its associated neurological diseases.

2 Aug 2022

Schizophrenia News and Research

Latest Schizophrenia News and Research

In vivo imaging of α-synuclein aggregates in the brains of living patients with multiple system atrophy

Study reveals clues what makes the human brain distinct from others

From book stacks to psychosis and food stamps, librarians confront a new workplace

New study advances the understanding of genetic basis of autism

UNC scientists map the surface of young brain's cortex with unprecedented resolution

The QCOVID4 algorithm developed using data from the Omicron wave identifies those at highest risk of severe COVID-19 outcomes

Metabolic Mind Award Program recognizes champions in the emerging field of metabolic psychiatry

Scientists unravel the development of main immune cell population residing in the brain

Researchers develop a long-acting injectable formulation of the anti-TB drug rifabutin

When mental illness leads to dropped charges, patients often go without stabilizing care

BBRF hosts a free webinar on manipulating memories to help treat brain illness

Neurons show rhythmic activity at different frequencies in the desynchronized state

Study identifies pivotal role of FIBCD1 gene in neurodevelopmental disorders

Researchers characterize a novel gene likely to cause neurological disorders in humans

Brain & Behavior Research Foundation recognizes exceptional research in mental illness

Repurposing an antipsychotic drug to treat various types of cancer

People who use high potency cannabis more likely to experience addiction, psychotic disorder

What is the role of psychedelic drugs in the treatment of psychiatric disorders?

New research may lead to early diagnosis of devastating mental health conditions

AbbVie Submits Marketing Authorization Application to EMA for Atogepant for the Preventive Treatment of Migraine

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Schizophrenia News and Research

Latest Schizophrenia News and Research

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Newsletters you may be interested in